Adult Liver Carcinoma — Trials

Adult Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

67 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 17.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00047346	Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction	completed	Phase 1	24	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials
NCT00030498	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	completed	Phase 1	75	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials